Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
Halfdanarson TR, Foster NR, Kim GP, Meyers JP, Smyrk TC, McCullough AE, Ames MM, Jaffe JP, Alberts SR. Halfdanarson TR, et al. Oncologist. 2019 May;24(5):589-e160. doi: 10.1634/theoncologist.2018-0878. Epub 2019 Jan 24. Oncologist. 2019. PMID: 30679315 Free PMC article. Clinical Trial.
Obesity adversely affects survival in pancreatic cancer patients.
McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de Andrade M, Reid-Lombardo K, Bamlet WR. McWilliams RR, et al. Among authors: halfdanarson tr. Cancer. 2010 Nov 1;116(21):5054-62. doi: 10.1002/cncr.25465. Cancer. 2010. PMID: 20665496 Free PMC article.
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.
Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, McWilliams RR, Lazaridis KN, Ramanathan RK, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Cuyugan L, McDonald J, Adkins J, Mastrian SD, Valdez R, Jaroszewski DE, Von Hoff DD, Craig DW, Stewart AK, Carpten JD, Bryce AH. Borad MJ, et al. Among authors: halfdanarson tr. Sci Rep. 2016 Dec 23;6(1):25. doi: 10.1038/s41598-016-0021-4. Sci Rep. 2016. PMID: 28003660 Free PMC article.
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.
Bryce AH, Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, McCullough AE, Hunt KS, Ritacca NR, Barrett MT, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, Stanton ML, Cheville J, Swanson S, Schneider DE, McWilliams RR, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Cuyugan L, McDonald J, Adkins J, Mastrian SD, Von Hoff DD, Craig DW, Stewart AK, Carpten JD. Bryce AH, et al. Among authors: halfdanarson tr. Clin Genitourin Cancer. 2017 Aug;15(4):e727-e734. doi: 10.1016/j.clgc.2016.11.001. Epub 2016 Dec 1. Clin Genitourin Cancer. 2017. PMID: 28057415 Free PMC article. No abstract available.
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
Huffman BM, Jin Z, Yadav S, Patel S, Nagorney DM, Truty MJ, McWilliams RR, Halfdanarson TR, Mahipal A. Huffman BM, et al. Among authors: halfdanarson tr. Clin Colorectal Cancer. 2019 Sep;18(3):218-225. doi: 10.1016/j.clcc.2019.05.002. Epub 2019 May 15. Clin Colorectal Cancer. 2019. PMID: 31178274
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors.
Liu AJ, Ueberroth BE, McGarrah PW, Buckner Petty SA, Kendi AT, Starr J, Hobday TJ, Halfdanarson TR, Sonbol MB. Liu AJ, et al. Among authors: halfdanarson tr. Oncologist. 2021 May;26(5):383-388. doi: 10.1002/onco.13686. Epub 2021 Feb 8. Oncologist. 2021. PMID: 33496040 Free PMC article.
219 results